Date updated:02-18-2009
Considering it's widely believed that President Obama will soon issue an executive order lifting the ban on federal funding for embryonic stem-cell research -- what's the trade?

-
GERN
Geron Corporation - $5.66
- -0.70%
- $5.75
Geron [GERN] is the name many traders talk about as a leader in stem cell research, says Pete Najarian. However, it’s important to keep in mind that major breakthroughs are probably a way out, still.

-
CELG
Celgene Corporati - $53.48
- -0.47%
- $53.53
In the larger space I like Celgene [CELG], Genzyme [GENZ] and Teva [TEVA] for their pipelines. Personally, my favorite stock in the space is Celgene, adds Guy Adami.

-
GENZ
Genzyme Corporati - $49.28
- -7.32%
- $53.06
In the larger space I like Celgene [CELG], Genzyme [GENZ] and Teva [TEVA] for their pipelines. - Pete Najarian

-
TEVA
Teva Pharmaceutic - $52.28
- +0.13%
- $52.37
In the larger space I like Celgene [CELG], Genzyme [GENZ] and Teva [TEVA] for their pipelines. - Pete Najarian

-
XBI
Spdr S&p Biotech - $50.31
- -0.77%
- $50.82
Or if you don’t want to play stock picker, you can get broad exposure with the SPDR S&P Biotech ETF[XBI]. - Pete Najarian

-
IBB
Ishares Trust - $78.21
- -0.11%
- $78.26
Or you can play the iShares NASDAQ Biotechnology Index ETF [IBB], adds Karen Finerman.
- Fast Money's Stem Cell Stock Picks's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. Charlie Munger
- 5. Calamos Advisors
- show all
- Top Do-It-Yourself Portfolios
- » John Shier
- » Joy
- » tsamanuli Portfolio 1
- » Albo's First Portfolio
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Roberto Pedone According to Jim Cramer, investors shouldn’t read too much into Thursday’s market action. He reminded investors that the market has gone up for six...
By Roberto Pedone Posted on Nov. 12, 2009 According to CNBC’s “Fast Money” traders, stocks continued to move higher this week, maintaining their strength off the ...
By Jonas Elmerraji Posted on Nov. 11, 2009 Recently we put our short-squeeze focus on smaller stocks; this week we’re going large-cap. With higher trading volumes, mo...
By Jonas Elmerraji Posted on Nov. 10, 2009 After six straight days of gains, the markets are taking a breather today, which gives us the chance to focus our attention b...
A. The only one I own : SLX,
too hard pick a winner out all of them
Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 13, 2009. more
These are the stocks from Jim Cramer's Nov. 12 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more
Here is the stock list of some of the largest % losers from Nov. 13, 2009. more











Comments not available